Summary
Samenvatting Klinische Psychiatrie (1002768BER)
- Course
- Institution
Deze samenvatting omvat alle informatie uit de slides, inclusief eigen notities.
[Show more]
Seller
Follow
irisvantomme
Reviews received
Content preview
KLINISCHE PSYCHIATRIESamenvatting
DOCENT: Prof. Dr. Dirk van West
Iris Vantomme
1ste schakeljaar – Semester 1
2022 – 2023
Psychologie & Educatiewetenschappen
,Inhoudsopgave
COLLEGE 1 - INLEIDING (DSM-5) ..................................................................................................................... 7
1 Psychopathologie/psychiatrische stoornis ................................................................................................ 7
1.1 Psychopathologie ............................................................................................................................ 7
1.2 Psychiatrische stoornis .................................................................................................................... 8
2 Classificatie ............................................................................................................................................... 9
2.1 Algemeen ........................................................................................................................................ 9
2.2 Categoriale, dimensionale en prototypische classificatie ............................................................... 9
2.3 DSM/ICD ........................................................................................................................................ 10
2.4 DSM: Voor-en nadelen .................................................................................................................. 10
2.5 Geschiedenis ................................................................................................................................. 11
3 Diagnostiek ............................................................................................................................................. 11
3.1 Verschillen tussen classificatie en diagnostiek .............................................................................. 11
4 Globale veranderingen DMS-5 ................................................................................................................ 11
5 Opzet DSM-5 ........................................................................................................................................... 12
5.1 Veranderingen deel II .................................................................................................................... 12
5.2 Deel III ........................................................................................................................................... 14
6 Stellingen ................................................................................................................................................ 14
7 Conclusie ................................................................................................................................................. 14
COLLEGE 2 - INLEIDING 2.0 ........................................................................................................................... 15
1 Normaliteit en psychopathologie............................................................................................................ 15
1.1 Normaliteit .................................................................................................................................... 15
2 Probleem van de subjectiviteit ................................................................................................................ 16
2.1 Individuele subjectiviteit ............................................................................................................... 16
2.2 Sociaal-culturele subjectiviteit ...................................................................................................... 16
3 Epidemiologie ......................................................................................................................................... 16
4 Algemene prevalentie ............................................................................................................................. 17
4.1 Prevalentie psychiatrische stoornissen ......................................................................................... 17
5 Etiopathogenese ..................................................................................................................................... 18
5.1 Fysiopathogenese ......................................................................................................................... 18
5.2 Psychopathogenese ...................................................................................................................... 21
6 Het psychiatrisch onderzoek ................................................................................................................... 26
6.1 Anamnese ..................................................................................................................................... 26
6.2 Onderzoek ..................................................................................................................................... 27
6.3 Beeldvorming ................................................................................................................................ 27
COLLEGE 3 – NEUROCOGNITIEVE STOORNISSEN ........................................................................................... 28
1 Neurocognitie: algemeen ....................................................................................................................... 28
1.1 Bevolkingspiramides ..................................................................................................................... 28
1.2 Algemeen – Vergrijzing van de bevolking in België ....................................................................... 28
1.3 Epidemiologie................................................................................................................................ 28
1.4 Het geheugen ................................................................................................................................ 29
2
, 1.5 Ouderdom ..................................................................................................................................... 29
2 Neuropsychologische testing .................................................................................................................. 30
2.1 MMSE ............................................................................................................................................ 30
2.2 Kloktest ......................................................................................................................................... 32
3 Dementie ................................................................................................................................................ 32
3.1 Informatie netwerk ....................................................................................................................... 32
3.2 Geheugen en veroudering ............................................................................................................ 32
3.3 Epidemiologie – Expertisecentrum dementie Vlaanderen ........................................................... 32
3.4 Klinische kenmerken ..................................................................................................................... 33
3.5 Oorzaken ....................................................................................................................................... 35
3.6 Types ............................................................................................................................................. 36
3.7 Etiopathogenesis ........................................................................................................................... 38
3.8 Diagnostiek.................................................................................................................................... 39
3.9 Dementie – Depressie ................................................................................................................... 39
3.10 Behandeling .................................................................................................................................. 40
4 Delirium .................................................................................................................................................. 41
4.1 Epidemiologie................................................................................................................................ 41
4.2 DSM ............................................................................................................................................... 41
4.3 Subtypes ........................................................................................................................................ 42
4.4 Delirium – dementie – depressie .................................................................................................. 42
4.5 Oorzaken delier: I WATCH DEATH ................................................................................................. 43
4.6 Behandeling .................................................................................................................................. 43
5 Amnestische stoornissen......................................................................................................................... 43
COLLEGE 4 - MIDDELENGERELATEERDE EN VERSLAVINGSSTOORNISSEN ....................................................... 44
1 Stoornissen in het gebruik ...................................................................................................................... 44
1.1 Middelenmisbruik ......................................................................................................................... 44
1.2 Middelenafhankelijkheid............................................................................................................... 44
2 Stoornissen door het gebruik .................................................................................................................. 45
2.1 Intoxicatie door een middel .......................................................................................................... 45
2.2 Onthouding van een middel .......................................................................................................... 45
2.3 Psychoactieve stoffen ................................................................................................................... 46
2.4 Alcohol (eenheid) .......................................................................................................................... 47
3 Diagnostiek ............................................................................................................................................. 48
3.1 Diagnostiek.................................................................................................................................... 48
3.2 Belang vroegdetectie en screening ............................................................................................... 48
4 Etiopathogenese ..................................................................................................................................... 49
4.1 Medisch biologisch model............................................................................................................. 49
4.2 Leertheoretisch model .................................................................................................................. 50
5 Prognose ................................................................................................................................................. 50
6 Behandeling ............................................................................................................................................ 51
COLLEGE 5 - SCHIZOFRENIE EN ANDERE PSYCHOTISCHE STOORNISSSEN ....................................................... 52
1 Psychotische stoornissen ........................................................................................................................ 52
2 Schizofrenie ............................................................................................................................................. 52
3
, 2.1 Klinische criteria ............................................................................................................................ 52
2.2 Kenmerken .................................................................................................................................... 53
2.3 Co-morbiditeit, typering, DD, diagnostiek .................................................................................... 57
2.4 Epidemiologie................................................................................................................................ 58
2.5 Etiopathogenese ........................................................................................................................... 59
2.6 Preventie ....................................................................................................................................... 61
2.7 Behandeling .................................................................................................................................. 61
2.8 Prognose, beloop .......................................................................................................................... 64
3 Schizofreniforme stoornis ....................................................................................................................... 64
3.1 Klinische criteria ............................................................................................................................ 64
4 Schizoaffectieve stoornis......................................................................................................................... 65
4.1 Klinische criteria ............................................................................................................................ 65
5 Waanstoornis.......................................................................................................................................... 65
5.1 Klinische criteria ............................................................................................................................ 65
5.2 Varianten ....................................................................................................................................... 65
6 Kortdurende psychotische stoornis ......................................................................................................... 66
6.1 Klinische criteria ............................................................................................................................ 66
7 Gedeelde psychotische stoornis .............................................................................................................. 66
7.1 Klinische criteria ............................................................................................................................ 66
COLLEGE 6 – STEMMINGSSTOORNISSEN ....................................................................................................... 67
1 Definities episodes .................................................................................................................................. 67
1.1 Symptoomcriteria (5 of meer) depressieve episode ..................................................................... 67
1.2 Symptoomcriteria (Hypo)manische episode ................................................................................. 68
1.3 Symptoomcriteria gemengde episode .......................................................................................... 69
2 Kenmerken stemmingsstoornissen ......................................................................................................... 69
2.1 Uni: depressie, dysthymie ............................................................................................................. 69
2.2 Bi: Bip st type 1, 2, clyclothymie ................................................................................................... 71
3 Diagnostiek, DD en comorbiditeit ........................................................................................................... 72
4 Epidemiologie & etiopathogenese .......................................................................................................... 73
4.1 Epidemiologie................................................................................................................................ 73
4.2 Etiopathogenese/fysiopathogese ................................................................................................. 73
4.3 Etiopathogenese/psychopathogenese.......................................................................................... 74
4.4 Verklaringsmodel .......................................................................................................................... 75
5 Prognose depressieve stoornis - beloop .................................................................................................. 75
6 Behandeling ............................................................................................................................................ 76
6.1 Algemeen ...................................................................................................................................... 76
6.2 Psychotherapie.............................................................................................................................. 76
6.3 Psychofarmaca .............................................................................................................................. 77
6.4 Andere ........................................................................................................................................... 77
7 Suïcide ..................................................................................................................................................... 78
7.1 Prevalentie .................................................................................................................................... 78
7.2 Suïcidaal proces............................................................................................................................. 78
7.3 Waarschuwingssignalen ................................................................................................................ 79
7.4 Exploratie suïcidaliteit ................................................................................................................... 80
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller irisvantomme. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $8.57. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
67474 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now